Title 902 | Chapter 045 | Regulation 001
PREVIOUS VERSION
The previous document that this document is based upon is available.
902 KAR 45:001.Definitions for hemp-derived cannabinoid products.
Section 1.
Definitions.(1)
"Adult-use cannabinoid" means a product with intoxicating properties that changes the function of the nervous system and results in alterations of perception, cognition, or behavior.(2)
"Approved source" means:(a)
A Kentucky hemp grower or handler licensed by the Kentucky Department of Agriculture, or an out-of-state hemp grower or handler who is duly authorized to produce hemp under the laws of the applicable jurisdiction;(b)
A hemp product manufacturer or processor permitted by the Kentucky Department for Public Health; or(c)
A manufacturer or processor permitted by another state regulatory authority for hemp-derived cannabinoid products if that state has been approved by the department as having equivalent state standards for processing, laboratory testing, and labeling requirements.(3)
"Cabinet" is defined by KRS 217.015(3).(4)
"Cannabidiol" or "CBD" is defined by KRS 217.039(1)(a).(5)
"Cannabinoid" means a compound found in the hemp plant Cannabis sativa L from a United States Department of Agriculture sanctioned domestic hemp production program and does not include cannabinoids derived from any other substance.(6)
"Cannabinoid product class" means a group of cannabinoid products that:(a)
Have all ingredients in common; and(b)
Are produced by or for the same company.(7)
"Cartoon" means any drawing or other depiction of an object, person, animal, creature, or any similar caricature that satisfies any of the following criteria:(a)
The use of comically exaggerated features;(b)
The attribution of human characteristics to animals, plants or other objects, or the similar use of anthropomorphic technique; or(c)
The attribution of unnatural or extra-human abilities, such as imperviousness to pain or injury, X-ray vision, tunneling at very high speeds, or transformation.(8)
''Child-resistant'' means packaging that is:(a)
Designed or constructed to be significantly difficult for children under five (5) years of age to open and not difficult for adults to use properly; and(b)
Resealable to maintain this effectiveness for children through multiple openings for any product intended for more than a single use or containing multiple servings.(9)
"Cosmetic" is defined by KRS 217.015(7).(10)
"Direct supervision" means the continuous, on-site observation of an employee with the supervisor physically present.(11)
"Food service establishment" is defined by KRS 217.015(21).(12)
"Hemp" is defined by KRS 260.850(5).(13)
"Hemp-derived cannabinoid" means an ingestible, inhalable, or cosmetic product that is processed or derived from hemp.(14)
"Home-based processor" is defined by KRS 217.015(56).(15)
"Hydrogenation" means the chemical reaction between molecular hydrogen (H2) and another compound or element.(16)
"Imminent health hazard" is defined by KRS 217.015(24).(17)
"Infused" means adding a cannabinoid ingredient to an ingestible cannabinoid product.(18)
"Non-intoxicating cannabinoid" means a product with non-psychoactive properties that does not change the function of the nervous system and does not result in alteration of perception, cognition, or behavior.(19)
"Person" is defined by KRS 217.015(32).(20)
"Proof of age" is defined by KRS 438.305(4).(21)
"Revocation" means the permit to operate is cancelled by the department.(22)
"Serious adverse event" means a medical occurrence associated with the use of a cannabinoid product that results in:(a)
Death;(b)
A life-threatening event;(c)
Inpatient hospitalization, or prolongation of an existing hospitalization;(d)
A persistent or significant incapacity, or substantial disruption in the ability to conduct normal life functions; or(e)
A congenital anomaly or birth defect.(23)
"Tentatively identified compounds" or "TIC" means compounds detected in a sample that are not among the target analytes.HISTORY: (50 Ky.R. 2535; 51 Ky.R. 68, 909, 1118; eff. 11-18-2024.)
FILED WITH LRC: November 18, 2024
CONTACT PERSON: Julie Brooks, Policy Specialist, Dept. for Public Health, 275 East Main St., HS1GW-A, Frankfort, Kentucky 40621; phone (502) 564-3970; email julied.brooks@ky.gov.
902 KAR 45:001.Definitions for hemp-derived cannabinoid products.
Section 1.
Definitions.(1)
"Adult-use cannabinoid" means a product with intoxicating properties that changes the function of the nervous system and results in alterations of perception, cognition, or behavior.(2)
"Approved source" means:(a)
A Kentucky hemp grower or handler licensed by the Kentucky Department of Agriculture, or an out-of-state hemp grower or handler who is duly authorized to produce hemp under the laws of the applicable jurisdiction;(b)
A hemp product manufacturer or processor permitted by the Kentucky Department for Public Health; or(c)
A manufacturer or processor permitted by another state regulatory authority for hemp-derived cannabinoid products if that state has been approved by the department as having equivalent state standards for processing, laboratory testing, and labeling requirements.(3)
"Cabinet" is defined by KRS 217.015(3).(4)
"Cannabidiol" or "CBD" is defined by KRS 217.039(1)(a).(5)
"Cannabinoid" means a compound found in the hemp plant Cannabis sativa L from a United States Department of Agriculture sanctioned domestic hemp production program and does not include cannabinoids derived from any other substance.(6)
"Cannabinoid product class" means a group of cannabinoid products that:(a)
Have all ingredients in common; and(b)
Are produced by or for the same company.(7)
"Cartoon" means any drawing or other depiction of an object, person, animal, creature, or any similar caricature that satisfies any of the following criteria:(a)
The use of comically exaggerated features;(b)
The attribution of human characteristics to animals, plants or other objects, or the similar use of anthropomorphic technique; or(c)
The attribution of unnatural or extra-human abilities, such as imperviousness to pain or injury, X-ray vision, tunneling at very high speeds, or transformation.(8)
''Child-resistant'' means packaging that is:(a)
Designed or constructed to be significantly difficult for children under five (5) years of age to open and not difficult for adults to use properly; and(b)
Resealable to maintain this effectiveness for children through multiple openings for any product intended for more than a single use or containing multiple servings.(9)
"Cosmetic" is defined by KRS 217.015(7).(10)
"Direct supervision" means the continuous, on-site observation of an employee with the supervisor physically present.(11)
"Food service establishment" is defined by KRS 217.015(21).(12)
"Hemp" is defined by KRS 260.850(5).(13)
"Hemp-derived cannabinoid" means an ingestible, inhalable, or cosmetic product that is processed or derived from hemp.(14)
"Home-based processor" is defined by KRS 217.015(56).(15)
"Hydrogenation" means the chemical reaction between molecular hydrogen (H2) and another compound or element.(16)
"Imminent health hazard" is defined by KRS 217.015(24).(17)
"Infused" means adding a cannabinoid ingredient to an ingestible cannabinoid product.(18)
"Non-intoxicating cannabinoid" means a product with non-psychoactive properties that does not change the function of the nervous system and does not result in alteration of perception, cognition, or behavior.(19)
"Person" is defined by KRS 217.015(32).(20)
"Proof of age" is defined by KRS 438.305(4).(21)
"Revocation" means the permit to operate is cancelled by the department.(22)
"Serious adverse event" means a medical occurrence associated with the use of a cannabinoid product that results in(a)
Death;(b)
A life-threatening event;(c)
Inpatient hospitalization, or prolongation of an existing hospitalization;(d)
A persistent or significant incapacity, or substantial disruption in the ability to conduct normal life functions; or(e)
A congenital anomaly or birth defect.(23)
"Tentatively identified compounds" or "TIC" means compounds detected in a sample that are not among the target analytes.(24)
HISTORY: (50 Ky.R. 2535; 51 Ky.R. 68, 909, 1118; eff. 11-18-2024.)
FILED WITH LRC: November 18, 2024
CONTACT PERSON: Julie Brooks, Policy Specialist, Dept. for Public Health, 275 East Main St., HS1GW-A, Frankfort, Kentucky 40621; phone (502) 564-3970; email julied.brooks@ky.gov.